cs.LGMar 16, 2026

IgPose: A Generative Data-Augmented Pipeline for Robust Immunoglobulin-Antigen Binding Prediction

Authors: Tien-Cuong Bui, Injae Chung, Wonjun Lee, Junsu Ko, Juyong Lee

Organizations: Arontier Co., Ltd., 241 Gangnam-daero, Seocho-gu, 06735, Seoul, Republic of Korea · Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, 08826, Seoul, Republic of Korea · Research Institute of Pharmaceutical Science, College of Pharmacy, Seoul National University, 08826, Seoul, Republic of Korea

Abstract

Predicting immunoglobulin-antigen (Ig-Ag) binding remains a significant challenge due to the paucity of experimentally-resolved complexes and the limited accuracy of de novo Ig structure prediction. We introduce IgPose, a generalizable framework for Ig-Ag pose identification and scoring, built on a generative data-augmentation pipeline. To mitigate data scarcity, we constructed the Structural Immunoglobulin Decoy Database (SIDD), a comprehensive repository of high-fidelity synthetic decoys. IgPose integrates equivariant graph neural networks, ESM-2 embeddings, and gated recurrent units to synergistically capture both geometric and evolutionary features. We implemented interface-focused k-hop sampling with biologically guided pooling to enhance generalization across diverse interfaces. The framework comprises two sub-networks--IgPoseClassifier for binding pose discrimination and IgPoseScore for DockQ score estimation--and achieves robust performance on curated internal test sets and the CASP-16 benchmark compared to physics and deep learning baselines. IgPose serves as a versatile computational tool for high-throughput antibody discovery pipelines by providing accurate pose filtering and ranking. IgPose is available on GitHub (https://github.com/arontier/igpose).

Figures & tables

Explore similar work

May 20, 2026

AgForce Enables Antigen-conditioned Generative Antibody Design

Antibody design methods condition on antigen structure to generate complementarity-determining regions (CDR), yet a systematic evaluation of baseline methods reveals that they largely ignore the antigen input. We identify three failure modes that explain this behavior. Antigen blindness arises because models derive predictions from antibody framework context rather than antigen information, producing nearly identical CDRs regardless of the target. Vocabulary collapse reduces predicted amino acids to three to five per position, far below the ground truth distribution in native sequences. Moreover, any model trained with standard per-position cross-entropy converges to the positional marginal distribution, making it provably unable to produce antigen-specific sequence predictions. We propose a novel encoder-decoder architecture called AgForce, that uses a graph neural network (GNN) as the encoder and specialized decoders for sequence-structure co-design. Specifically, we apply framework dropout, gated bottlenecks, and hyperbolic cross attention that prevent the antibody shortcut path. In the decoder, a Mixture Density Network (MDN) sequence head with Potts-like pairwise coupling and annealed Multiple Choice Learning (aMCL) replaces the cross-entropy objective with a multi-component distribution whose optimal solution differs from the positional marginal. An antigen cycle consistency head routes gradients through the sequence decoder, forcing predicted distributions to encode antigen identity. AgForce achieves the best binding quality and sequence recovery simultaneously on the CHIMERA-Bench dataset, improving amino acid recovery by 8% over the strongest sequence baseline while surpassing the baselines across all interface metrics, and nearly doubling the effective vocabulary of GNN methods. The source code is available at: https://github.com/mansoor181/ag-force.git
Sep 28, 2026

AbGaze: Attentive Geometric Representation Learning for End-to-End Antibody Design

Computational antibody design requires representations that capture the geometric patterns underlying antigen--antibody interactions, yet existing approaches often rely on scalar distances or surface-intrinsic features, leaving cross-molecular geometry largely implicit. We present AbGaze, an end-to-end antibody design framework based on attentive geometric representation learning, which encodes distance, spatial direction, and surface-normal orientation of antigen surfaces relative to antibody-residue local frames, and adaptively aggregates these geometric interactions according to their interfacial context. The learned interaction representation is shared across multi-CDR co-design, complex structure prediction, and affinity optimization, with local-frame geometric supervision further constraining the representation. AbGaze outperforms prior methods across all three tasks: relative to the second-best method, it improves amino-acid recovery by 7.1% and reduces structural error by 14.9% on average over the six CDRs, improves interface docking quality (DockQ) by 6.6%, and raises the affinity improvement rate (IMP) by 32.5%.
Dec 26, 2025

DuaDeep-SeqAffinity: Dual-Branch Deep Learning for Tri-Stream Sequence-Based Antibody--Antigen Affinity Prediction

DuaDeep-SeqAffinity is a sequence-only deep learning framework that predicts antibody--antigen binding affinity directly from primary amino acid sequences, avoiding the cost and scarcity of resolved three-dimensional structures. The antigen and the antibody heavy and light chains are processed as three independent streams, each embedded with a frozen ESM-2 protein language model and passed through parallel Transformer and convolutional neural network (CNN) branches before late fusion, a decoupled design intended to preserve local complementarity-determining region (CDR) signal that monolithic encoders can dilute. On a sequence-disjoint split of the AbRank benchmark, the model achieves a Pearson correlation of 0.683, an R^2 of 0.460, and a pairwise ranking AUC of 0.895, significantly outperforming single-branch ablations (paired t-test, p < 0.05). Attention-map and gradient-based saliency analyses further show that the model preferentially attends to CDR loops and candidate epitope residues, supporting its use as a scalable, structure-free tool for high-throughput antibody screening.